Synairgen Plc (UK) Today
| SNG Stock | 1.90 0.10 5.00% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Synairgen Plc is trading at 1.90 as of the 6th of March 2025, a 5 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.8. Synairgen Plc has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 4th of February 2025 and ending today, the 6th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Synairgen Plc is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 1.1 B outstanding shares. More on Synairgen plc
Moving against Synairgen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Synairgen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Synairgen Plc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Synairgen Plc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| MD CEO | Richard Marsden | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Synairgen Plc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Synairgen Plc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsSynairgen Plc can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Synairgen Plc's financial leverage. It provides some insight into what part of Synairgen Plc's total assets is financed by creditors.
| |||||
Synairgen plc (SNG) is traded on London Exchange in UK and employs 36 people. Synairgen Plc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Synairgen Plc's market, we take the total number of its shares issued and multiply it by Synairgen Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Synairgen plc operates under Biotechnology sector and is part of Health Care industry. The entity has 1.1 B outstanding shares.
Synairgen Plc generates negative cash flow from operations
Check Synairgen Plc Probability Of Bankruptcy
Ownership AllocationSynairgen plc shows a total of 1.1 Billion outstanding shares. The majority of Synairgen plc outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Synairgen Plc to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Synairgen plc. Please pay attention to any change in the institutional holdings of Synairgen plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Synairgen Ownership Details
Synairgen plc Risk Profiles
Although Synairgen Plc's alpha and beta are two of the key measurements used to evaluate Synairgen Plc's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 6.85 | |||
| Standard Deviation | 10.85 | |||
| Variance | 117.82 | |||
| Risk Adjusted Performance | (0.03) |
Synairgen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Synairgen Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Synairgen Plc Corporate Management
Elected by the shareholders, the Synairgen Plc's board of directors comprises two types of representatives: Synairgen Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synairgen. The board's role is to monitor Synairgen Plc's management team and ensure that shareholders' interests are well served. Synairgen Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synairgen Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gareth Walters | Chief Officer | Profile | |
| Richard Francis | Senior Quality | Profile | |
| Simon Esq | Company Secretary | Profile | |
| Jody Brookes | Senior Operations | Profile | |
| Phillip Monk | Chief Board | Profile |
Other Information on Investing in Synairgen Stock
Synairgen Plc financial ratios help investors to determine whether Synairgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Synairgen with respect to the benefits of owning Synairgen Plc security.